ASX - By Stock
|
KZA |
Re:
International Brokerage Accounts
|
|
Oupa
|
15 |
5.7K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
International Brokerage Accounts
|
|
Oupa
|
15 |
5.7K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
15
|
5.7K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
International Brokerage Accounts
|
|
Oupa
|
15 |
5.7K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
International Brokerage Accounts
|
|
Oupa
|
15 |
5.7K |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
15
|
5.7K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
Oupa
|
133 |
46K |
6 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
133
|
46K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
Oupa
|
133 |
46K |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
133
|
46K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
Oupa
|
133 |
46K |
0 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
133
|
46K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
Oupa
|
133 |
46K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
133
|
46K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Oupa
|
54 |
18K |
3 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
54
|
18K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
71
|
19K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
71
|
19K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
0 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
71
|
19K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
71
|
19K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
1 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
71
|
19K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
Oupa
|
71 |
19K |
1 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
71
|
19K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Oupa
|
54 |
18K |
1 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
54
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Oupa
|
54 |
18K |
1 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
54
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Oupa
|
54 |
18K |
2 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
54
|
18K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
Oupa
|
22 |
6.7K |
2 |
02/09/23 |
02/09/23 |
ASX - By Stock
|
22
|
6.7K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
Oupa
|
103 |
39K |
1 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
103
|
39K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
Oupa
|
103 |
39K |
2 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
103
|
39K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents new data at AACR Annual Meeting
|
|
Oupa
|
36 |
14K |
0 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
36
|
14K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents new data at AACR Annual Meeting
|
|
Oupa
|
36 |
14K |
11 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
36
|
14K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia result of Share Purchase Plan
|
|
Oupa
|
14 |
5.2K |
7 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
14
|
5.2K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia result of Share Purchase Plan
|
|
Oupa
|
14 |
5.2K |
0 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
14
|
5.2K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: EVT801 preclinical data published
|
|
Oupa
|
47 |
13K |
5 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
47
|
13K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Oupa
|
26 |
6.4K |
2 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
26
|
6.4K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Oupa
|
26 |
6.4K |
0 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
26
|
6.4K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Its a dead duck
|
|
Oupa
|
69 |
25K |
5 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
69
|
25K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 8 August 2022
|
|
Oupa
|
15 |
8.5K |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
15
|
8.5K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
6 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
11K
|
5.4M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CORE NK Platform Phase 1 Clinical Data Presentation
|
|
Oupa
|
53 |
13K |
5 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
53
|
13K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Oupa
|
73 |
45K |
0 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
73
|
45K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Oupa
|
73 |
45K |
4 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
73
|
45K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
3 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
11K
|
5.4M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
4 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
11K
|
5.4M
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
4 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
11K
|
5.4M
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notification regarding unquoted securities - KZA
|
|
Oupa
|
8 |
2.1K |
4 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
8
|
2.1K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q4 2021 quarterly activity and cash flow report
|
|
Oupa
|
42 |
18K |
12 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
42
|
18K
|
12
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Deck
|
|
Oupa
|
24 |
6.2K |
3 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
24
|
6.2K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Positive topline results from Phase 3 trial in Rett syndrome
|
|
Oupa
|
52 |
30K |
0 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
52
|
30K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Drilling confirms thick, high-calcium limestone
|
|
Oupa
|
71 |
19K |
1 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
71
|
19K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
1 |
18/12/21 |
18/12/21 |
ASX - By Stock
|
11K
|
5.4M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Oupa
|
11K |
5.4M |
0 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
11K
|
5.4M
|
0
|
|